SpeedWeed

SEPTEMBER 17, 2021

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. .

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

APRIL 21, 2022

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JUNE 19, 2022

The group advocates the urgent need for psychedelics, citing that mental health has become a serious societal crisis because we are lacking sufficient treatment options. Testimonial from a participant in psychedelic-assisted therapy. The other noteworthy milestones occurred when Imperial College London in the United Kingdom (U.K.)

Therapy 52

Therapy Advocacy Events Treatment 52

Cannabis Law Report

JULY 21, 2022

Working alongside our talented leadership team, he will leverage his extensive background in leading the commercialisation of innovative therapies to bring COMP360 psilocybin therapy to the large number of patients who are not currently being helped by existing treatments.”

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 209

Access Marijuana Treatment Legislation 209

Cannabis Law Report

SEPTEMBER 23, 2022

Policy and Advocacy Director, MAPS . Going forward, MAPS and its Policy & Advocacy team looks forward to continuing to support advancement in psychedelic policy through creative but evidence-based approaches, including a renewed commitment to advocate for state-funded harm reduction and education programs. ###.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

MMJ Recs

MARCH 6, 2024

Despite this, pockets of advocacy and research persisted, leading to the gradual recognition of its therapeutic potential and subsequent legalization for medical use in various states starting in the late 20th century. Its potential applications span from managing symptoms to improving quality of life, with individual responses varying.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

United Patients Group

APRIL 14, 2023

With more research being conducted on the effects of cannabis on appetite, we may see new treatments and therapies developed that utilize this plant’s unique properties. We believe patients should have access to safe and effective treatments and that education and advocacy are key to achieving this goal.

THC 52

THC Strains Research and Development Patients 52

NORML

FEBRUARY 13, 2019

Under existing regulations, VA doctors are not permitted to fill out the mandatory paperwork necessary to recommend cannabis therapy in those 33 states that regulate it. Click here to send a message to your federal lawmakers now!

Legislation 231

Legislation Access Chronic Pain Marijuana 231

SpeedWeed

APRIL 2, 2021

After traditional treatments for the disease were unsuccessful, Charlotte’s mother Paige Figi decided to try medicinal cannabis with tremendous results, which were documented by Gupta. The group also helps families in need of cannabinoid treatments, most of which are not covered by health insurance.

Events 52

Events Epilepsy Cannabinoids Treatment 52

Cannabis Law Report

DECEMBER 9, 2021

After working with Carter’s neurologist to balance TXOG’s medicine with other treatments, they noticed a difference in seizure reduction as well as improved behavioral control and sleep. The combined therapy of Carter’s anti-seizure prescriptions and TXOG’s medical cannabis has significantly improved his daily life.

Conditions 52

Conditions Patients Sleep Medicine 52

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. Online Educational Platforms: Websites and forums dedicated to medical cannabis education offer articles, videos, and resources covering various aspects of cannabis therapy.

Dispensary 52

Dispensary Patients Marijuana Education 52

Puff Puff Post

FEBRUARY 4, 2019

Physicians who treat young people now face a series of dilemmas: The anti-smoking therapies on the market — such as nicotine patches and gums — are not approved for children, due to lack of testing or ineffective results. And young people view the habit as far less risky, which poses another hurdle to quitting. About two-thirds of U.S.

Vaping 101

Vaping Therapy Programs Advocacy 101

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

SpeedWeed

MARCH 19, 2021

However, in Oregon, some psychedelics have been legalized in 2020 for mental health treatment. They were given the right to be treated with psilocybin therapies. For instance, an advocacy group, TheraPsil, led by a clinical psychologist, Bruce Tobin, has been pushing for psilocybin-use exemptions since 2016.

Environment 52

Environment Decriminalization Research and Development Advocacy 52

Cannabis Law Report

JUNE 23, 2021

The analysis of patient-reported outcome measures following treatment with cannabis-based medicinal products (CBMPs) in a study covering patients with all conditions found statistically significant improvements in anxiety, sleep , and general quality of life at one, three, and six months following treatment, compared to baseline assessment.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

APRIL 12, 2019

I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

MMJ Recs

APRIL 4, 2018

states legalizing medical marijuana (29 at last count), the drug is starting to be accepted as something more than simply an outlier treatment; it is a genuine, progressive form of therapy with tangible results. With over half of U.S. Patients in California don’t pay sales tax on MMJ. There Are Plenty of Vendors To Choose From.

Chronic Pain 40

Chronic Pain Marijuana Conditions Strains 40

NORML

FEBRUARY 22, 2019

Update : The Senate Rules Committee Committee unanimously approved an amended version of S182 on 2/20, only requiring a second opinion for terminally ill patients under 18, and also allowing treatment centers to sell paraphernalia. The bill will go to the Senate floor for a vote next. NV resident? New Hampshire.

Legislation 179

Legislation Hemp Compliance Compliance 179

SpeedWeed

AUGUST 16, 2021

As if this part of her resume isn’t impressive enough, Reiman also taught courses on substance abuse and treatment, and drug policy at U.C. Gardening, Understanding & Advocacy . and abroad. . Berkeley for 10 years.

Chronic Pain 52

Chronic Pain Dispensary Supply Chain THC 52

The Cannigma

DECEMBER 12, 2022

Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. Are psychedelics safe? 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

Veriheal

JUNE 21, 2023

If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments. His advocacy brings the drug reform movement to Capitol Hill. ” Recently, Sen.

Access 98

Access Legalization Research and Development Legislation 98

Cannabis Law Report

JULY 8, 2021

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA).

Legalization 98

Legalization Advocacy Legislation Cannabis 98

Cannabis Law Report

MAY 29, 2022

TORONTO , May 27, 2022 /CNW/ – 12 companies from across the country joined forces today to found Psychedelics Canada , the first, national-level trade association representing the blossoming psychedelic medicine and therapy industry. spark*advocacy. Psychedelics Canada Launch Press conference. .” Bloom Psychedelics.

Research and Development 52

Research and Development Legalization Therapy Advocacy 52

Cannabis Law Report

MARCH 19, 2022

Family members described her as changing from a “happy-go-lucky girl to a timid recluse that hardly speaks”, who now self-harms and needs therapy. According to the report, the impact on the secondary school pupil – referred to as Child Q – was “profound” and the repercussions “obvious and ongoing”.

Therapy 52

Therapy Education Safety Treatment 52

Cannabis Law Report

SEPTEMBER 21, 2021

He also is a member of the Board of Directors at the Bend Chamber of Commerce and the Chamber’s Advocacy Committee. And regulators need to be thinking in the best interests of consumers who rely on plant-based therapies for their health and quality of life. No, they need to be re-reviewed.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

FEBRUARY 16, 2022

We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. So, with that, we should get into it, but don’t forget to check out our segment with Americans for Safe Access. EG: All right, so that’s going to be straight up to the interview. Let’s listen to Steven.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

NORML

MARCH 14, 2019

Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. This simple bill would align veterans VA treatment with their very popular state laws, usually approved by the voters.

Access 215

Access Chronic Pain Treatment Conditions 215

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Healing Advocacy Fund. Sam is the Executive Director of the Healing Advocacy Fund, which is the nonprofit organization supporting the implementation of Measure 109 in Oregon. in/andrew-chadeayne-989b751/ [link]. Sam Chapman. in/sam-chapman-0a0a8229/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

NORML

FEBRUARY 8, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. CT resident? CT resident? OR resident?

Legislation 176

Legislation Decriminalization Patients Access 176

Cannabis Law Report

JULY 30, 2019

Even with all the past federal missteps and current obstacles, these determined medics want to help keep patients healthier and safer with natural, plant-derived medicine, rather than the more synthetic pharmaceutical alternatives that can prove to be even riskier therapies with highly addictive propensities. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

NORML

FEBRUARY 5, 2019

Jason Nemes, R-33, is sponsoring a medical cannabis bill (HB 136) that allows doctors to recommend cannabis therapy as part of patients’ treatment regimens. Seum recently told lawmakers he “smoked a joint” instead of using potentially addictive opioids during colon cancer treatment. 9 during a news conference.

Decriminalization 190

Decriminalization Legislation Treatment Therapy 190